Govt panel to review EUA application for generic Covid-19 pill

The subject expert committee (SEC) under India's drug regulator is expected to review the EUA applications of drug companies seeking approval for Merck’s antiviral pill, Molnupiravir, on Thursday.

from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/3Hsf43o